Moreover, as MC38 and B16F10 growth curves were comparable in Bcl6fl/fl Mb1-cre and Bcl6fl/fl mice, BCL6 insufficiency or derepression of its antagonized targets, such as BLIMP in B cells, likely does not affect tumor immunity (Fig 4D and E). The gene discussed is BCL6; the disease is neoplasm.